ADIPOQ and hepatocellular carcinoma: This suggests that adiponectin may affect the pathogenesis of prostate and hepatocellular carcinomas, which express AdipoR1 and R2 receptors, by acting on tumour cells directly through modulation of JNK and STAT3 (Miyazaki et al, 2005).